|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 405/14 | (2006.01) |
| C07D 401/10 | (2006.01) | ||
| C07D 235/16 | (2006.01) | ||
| C07D 403/10 | (2006.01) | ||
| C07D 405/10 | (2006.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| C07D 491/10 | (2006.01) | ||
| C07D 209/14 | (2006.01) | ||
| C07D 209/18 | (2006.01) | ||
| A61K 31/404 | (2006.01) | ||
| A61K 31/416 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 3307734 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16731721.3 |
| Date of filing the European patent application | 2016-06-08 | |
| (97) | Date of publication of the European application | 2018-04-18 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-27 |
| (46) | Date of publication of the claims translation | 2020-05-11 |
| (86) | Number | PCT/US2016/036283 |
| Date | 2016-06-08 |
| (87) | Number | WO 2016/200851 |
| Date | 2016-12-15 |
| (30) | Number | Date | Country code |
| PCT/IB2015/0016 | 2015-06-09 | WO | |
| 201562257806 P | 2015-11-20 | US | |
| 201662343905 P | 2016-06-01 | US |
| (72) |
ARGIRIADI, Maria, A., US
BREINLINGER, Eric, C., US
CUSACK, Kevin, P., US
HOBSON, Adrian, D., US
POTIN, Dominique, FR
BARTH, Martine, FR
AMAUDRUT, Jérōme, FR
POUPARDIN, Olivia, FR
MOUNIER, Laurent, FR
KORT, Michael, E., US
|
| (73) |
AbbVie Inc.,
1 North Waukegan Road, North Chicago, IL 60064,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Branduolinio receptoriaus moduliatoriai (ROR), skirti uždegiminių ir autoimuninių ligų gydymui |
| NUCLEAR RECEPTOR MODULATORS (ROR) FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES |
| Payment date | Validity (years) | Amount | |
| 2023-05-29 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-06-08 |